SAGES Magazine

THE SOUTH AFRICAN GASTROENTEROLOGY REVIEW 2022 | VOLUME 20 | ISSUE 1 | 46 There were similar colonoscopy findings for both HIV negative and HIV positive patients. PR bleeding being the commonest symptom (19% vs 16.6%), followed by constipation (11.9% vs 9.5%) in both groups. The most frequent findings for both groups were normal (9.5% vs 7.1%) and haemorrhoids (7.1% vs 9.5%). [Table 13] Table: 12: Gastroscopy symptoms, findings and histology of patients (n=300) based on HIV status Indications HIV Negative Patients % HIV Positive Patients % Epigastric pain 68 22,6% 28 9,3% Dysphagia 19 6,3% 13 4,3% Heartburn 28 9,3 11 3,6% Nausea and vomiting 10 3,3% 8 2,6% Upper GI- bleed 12 4% 6 1,3% Anaemia 9 3% 8 2,6% Loss of weight 3 1% 2 0,6% Abdominal pain 7 2,3% 1 0,3% Maelena stools 1 0,3% 3 1% Vomiting 0 0% 2 0,6% Hoarse voice 1 0,3% 0 0% Diarrhoea 3 1% 1 0,3% Dyspepsia 0 0% 1 0,3% Abdominal mass 0 0% 1 0,3% Nausea 1 0,3% 0 0% Findings Diffuse gastritis 49 16,3% 31 10,3% Hiatal hernia 16 5,3% 7 2,3% Oesophagitis 17 5,6% 11 3,6% Duodenitis 13 4,3% 7 2,3% Oesophageal candidiasis 6 2% 6 2% Antral gastritis 14 4,6% 1 0,3% Oesophageal malignancy 5 1,5% 1 0,3% Prepyloric ulcer 5 1,6% 2 0,6% Erosive gastritis 5 1,6% 2 0,6% Healed duodenal ulcer 3 1% 0 0% Poorly prepared 0 0% 0 0% Oesophageal stricture 1 0,3% 4 1,3% Bleeding 1 0,3% 0 0% Gastric candidiasis 2 0,6% 1 0,3% Pyloric stricture 2 0,6% 1 0,3% Atrophic gastritis 0 0% 0 0% Perforated gastric ulcer 1 0,3% 0 0% Oesophageal varices 1 0,3% 0 0% Histology Normal 3 1% 2 0,6% Gastritis 4 1,3% 1 0,3% Gastric ulcer 2 0,6% 0 0% Gastric cancer 2 0,6% 0 0% Oesophageal squamous cancer 6 2% 2 0,6% Barrett’s oesophagus 0 0% 1 0,3% Oesophageal candidiasis 0 0% 1 0,3% Oesophageal ulcer 0 0% 1 0,3% Kaposi sarcoma 0 0% 1 0,3% Table 13: Colonoscopy symptoms, findings of patients based on HIV status Symptoms HIV Negative % HIV Positive % PR bleeding 8 19% 7 16.6% Constipation 5 11,9% 4 9,5% Diarrhoea 0 0% 0 0% Suspected malignancy 2 4,7% 1 2,3% Loss of weight 1 2,3% 0 0% Abdominal pains 0 0% 1 2,3% CASE SERIES